• EU funding to improve immunotherapies

    The Tübingen Radiopharmacy develops new immune cell tracers:

    The University Hospital of Tübingen is participating in a Europe-wide research project on immune imaging.


    Read more

  • Successful application for Cluster of Excellence (iFIT)

    The Image-Guided and Functionally Instructed Tumor Therapies (iFIT) Cluster of Excellence succeeded in the application for a seven years funding period.

    Read more